Potency Testing

Measurement of cannabinoid concentrations, including THC, THCA, CBD, and minor cannabinoids, for regulatory compliance and product labeling.

What It Is

Potency Testing

Potency screening measures the cannabinoid content of a cannabis product, providing the data needed to verify product strength, support labeling requirements, and monitor production consistency.
Analysis is performed using validated HPLC-DAD methods, allowing the lab to measure potency with precision across different product types and sample matrices. This is especially important for formulated products that may contain oils, sugars, flavoring agents, emulsifiers, or other ingredients that can affect sample preparation.
For manufacturers, potency screening provides the analytical data needed to understand product strength, verify formulation targets, and support accurate product documentation.

Analytes Tested

  • Δ9-THC
  • THCA
  • CBD
  • CBDA
  • CBG
  • CBN
  • CBC
  • CBDV
  • CBGA
  • THCV
  • Δ8-THC

Why It Matters

Potency testing is a key part of cannabis product compliance and quality control. Missouri operators need reliable potency data to support labeling, product release, batch records, internal specifications, and consumer-facing product information.
For flower and concentrates, results help confirm product strength and provide a clear profile for each batch. For manufactured products such as edibles, beverages, tinctures, and topicals, this testing helps verify that active compounds are distributed and dosed consistently. This is especially important for non-inhalable products, where labeling and serving-size accuracy depend on consistent distribution.
Potency screening also supports operational consistency. If results differ from expected formulation targets, cultivators can use the data to review production variables, ingredient inputs, infusion processes, or batch-to-batch variation before products move forward.

Products Tested

Potency screening can be used for a wide range of cannabis products, including raw plant material, extracted materials, inhalable products, and finished goods.

Common product types include:

  • Flower
  • Pre-rolls
  • Concentrates
  • Extracts
  • Vape products
  • Edibles
  • Beverages
  • Tinctures
  • Topicals
  • Other non-inhalable cannabis products

Different product types may require different preparation steps because the sample matrix can affect how cannabinoids are extracted and measured. A flower sample, for example, is handled differently than a chocolate edible, infused beverage, or topical product. Product type is reviewed during intake, so the correct testing approach and sample requirements can be confirmed.

Includes

  • Major and minor compound profile analysis
  • Validated HPLC-DAD testing methods
  • Support for label claim and dosing review
  • Documentation that supports consistency monitoring across production runs
  • Product-specific sample preparation
  • Compliance-focused reporting
  • Results delivered through a Certificate of Analysis (COA)

Turnaround Expectations

Turnaround time depends on the product type, testing volume, sample matrix, and current laboratory schedule. Straightforward sample types may move through the process more quickly, while complex infused products can require additional preparation before analysis.
Expected timing is provided during sample intake based on the submitted product and requested testing needs. This helps manufacturers plan around compliance review, labeling, batch release, and production schedules.
For time-sensitive products, operators should contact the lab before submission to confirm sample requirements, timing expectations, and whether any scheduling considerations apply.

Other Services

View All Services